Life-saving brain cancer blood test being developed in Scotland

Tuesday April 30th, 2019

A University of Strathclyde spinout company, ClinSpec Diagnostics Limited, is developing a pioneering new blood test for the early detection of brain cancer. The low cost test provides rapid results, giving doctors an accurate test for brain cancer and reducing delays in referral times, which will ultimately lead to lives being saved.paperless medicine

The innovative blood test technology could be in use in UK hospitals in three to four years, with further blood tests being developed by the company for other diseases, such as pancreatic and prostate cancer.

During a visit to the company today to hear about its successes, Business Minister Jamie Hepburn said: “I’m pleased to visit ClinSpec Dx today to announce the £600,000 of funding from Scottish Enterprise that supported their spin-out from the University of Strathclyde and development of an innovative new blood test for brain cancer.

“The blood test demonstrates significant advancements in cancer detection methods, and will play a vital role in helping to save lives. This technology also paves the way for similar blood tests to be developed in the future for other diseases.

“By supporting this promising university spin-out, the Scottish Government is helping to translate key research outputs into practical medical innovations.”

Leave a Reply